Medincell secures EUR 13.8 million non-dilutive loan from European banks, Bpifrance

By Public Technologies
  • Medincell secured an additional EUR 13.8 million non-dilutive loan from leading European commercial banks and Bpifrance.
  • Total non-dilutive financing raised since July 2026 increased to EUR 41.8 million, including EUR 28 million announced in July 2026.
  • Loan terms were described as market-based, with no instruments providing access to equity, avoiding shareholder dilution.
  • Cash and cash equivalents stood at EUR 84.8 million as of March 31, 2026.
  • Medincell repaid EUR 23.2 million to the EIB in July 2026, including EUR 20 million of principal.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medincell SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20261013399867) on October 13, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.